https://orcid.org/0000-0001-8509-0882
Abstract
Introduction
The correlation among treatment satisfaction with demographic characteristics, health symptoms or psychological health, and quality of life with the prophylactic regime against COVID-19 is rather unexplored. This real-world exploratory study was conducted to determine patient-perspectives regarding their treatment satisfaction receiving Divya-Swasari-Coronil-Kit with correlative impacts on psychological health (PH) and Quality of life (QoL) based on four hypotheses each relating to PH, QoL, Demographic characteristics, and Treatment satisfaction.
Methods
This cross-sectional, web-based survey collected data on demographic characteristics and psychological health with DASS-21; QoL with 5-level 5-dimension EuroQol instrument; and treatment satisfaction using Treatment Satisfaction Questionnaire for Medication (TSQM) V9. Pearson correlation coefficient analysis was used to examine the relation between TSQM and PH and the demographic variables. Factor analysis was used for multi-collinearity tests, and multiple linear regression analysis was used to explore demographic variables and TSQM.
Results
Out of 421 initial screenings, 367 patient-participants were included in the analysis. The mean age of included participants was 33.61 ± 9.47 years. Marital status and socio-economic class positively correlated with TSQM. Physical symptoms in patients are positively correlated with depression, anxiety, and stress; and in contrast, negatively with QoL. Global satisfaction with Divya-Swasari-Coronil-Kit medication negatively correlated with depression, anxiety, stress, effectiveness, convenience; whereas global satisfaction correlated positively with QoL.
Conclusion
Present study (SATISFACTION COVID) indicates that treatment satisfaction due to avaliablity and treatment of Divya-Swasari-Coronil-Kit has constructive and beneficial implications on psychological health, Quality of life and demographic factors. In addition, web-based patient-reported perspectives may well be a feasible way to provide better insights into treatment satisfaction, in relation to psychological health and Quality of life.
Graphical abstract
Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use:
Data Sharing Statement
The data generated and/or analyzed in the SATISFACTION COVID study are for academic purposes and are available on appropriate requests.
Ethical Approval
The study was conducted in accordance with the Principles of the Declaration of Helsinki (1975). An institutional ethical committee exemption was obtained from IEC-Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar, India, for the study and data collection, as per National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, ICMR (2017).
Informed Consent
Informed consent was obtained electronically from the eligible patients volunteered in participating in the SATISFACTION COVID survey.
Acknowledgments
The authors are thankful to the volunteers who agreed to participate in the study and to Mr Deepak Rawat for assistance in patient recruitment. We extend our gratitude to Ms. Priyanka Kandpal, Mr. Tarun Rajput, Mr. Gagan Kumar, and Mr. Lalit Mohan for their swift administrative supports.
Author Contributions
All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; took part in drafting the article or revising it critically for important intellectual content; agreed to submit to the current journal; gave final approval of the version to be published, and agree to be accountable for all aspects of the work.
Disclosure
Divya-Swasari-Coronil-Kit has been manufactured by Divya Pharmacy, Haridwar India. Divya Pharmacy was not involved in any aspect of research reported in this study. Acharya Balkrishna is an honorary trustee in Divya Yog Mandir Trust; in addition, he holds an honorary managerial position in Patanjali Ayurved Ltd., Haridwar, India; he reports no other potential conflicts of interest for this work. All other authors declare no conflicts of interest for this work.